Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus

被引:2
作者
Mei, Shirley [1 ]
Gibbs, Jennifer [1 ]
Economos, Katherine [2 ]
Lee, Yi-Chun [1 ]
Kanis, Margaux J. [1 ]
机构
[1] Suny Downstate Med Ctr, Div Gynecol Oncol, 450 Clarkson Ave, Brooklyn, NY 11203 USA
[2] New York Presbyterian Brooklyn Methodist Hosp, Div Gynecol Oncol, Brooklyn, NY USA
关键词
Neuroendocrine Tumor; Uterine Neoplasms; Endometrioid Adenocarcinoma; SMALL-CELL-CARCINOMA; MULTIMODALITY THERAPY; ENDOCRINE TUMORS; CERVIX; CANCER;
D O I
10.3802/jgo.2019.30.e58
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To compare the clinicopathologic features and survival outcomes of neuroendocrine tumor of the uterine corpus (NET-U) to endometrioid type endometrial carcinoma (EC). Methods: From 1993 to 2012, the Surveillance, Epidemiology and End Results cancer registry was queried for women diagnosed with EC or NET-U. Data regarding stage, grade, presence of extra-uterine disease, lymph node metastasis, receipt of adjuvant radiation, surgical intervention and overall survival (OS) was extracted. Chi-square tests, t-tests and Kaplan Meir curves were used for statistical analysis. Results: A total of 98,363 patients were identified: 98,245 with EC and 118 with NET-U. The mean age at diagnosis for EC was 61.7 years and 64.8 years for NET-U (p=0.01). NET-U cases were more likely to be poorly differentiated (97.0% vs. 15.6%; p <= 0.01) and have nodal metastasis (56.4% vs. 11.1%; p <= 0.01) when compared to EC. Presence of extrapelvic disease at the time of diagnosis was observed more frequently in NET-U compared to EC, 49.1% vs. 4.8%, respectively (odds ratio=18; 95% confidence interval=13.1-27.2; p <= 0.01). Significant improvement in OS was observed in NET-U patient who received radiation (OS: 7.7 vs. 3.3 years; p <= 0.01) or underwent surgical management (5.6 vs. 0.9 years; p <= 0.01). The OS for EC was 14.4 vs. 4.6 years for NET-U (p <= 0.01). Conclusion: NET-U represents an aggressive form of uterine malignancy. When compared to EC, patients with NET-U present at more advanced stage, have more frequent extra-uterine disease and lower OS.
引用
收藏
页数:5
相关论文
共 50 条
[21]   Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature [J].
Bellefqih, S. ;
Khalil, J. ;
Mezouri, I. ;
Kebdani, T. ;
Benjaafar, N. .
CANCER RADIOTHERAPIE, 2014, 18 (03) :201-207
[22]   Neuroendocrine carcinoma of the uterine cervix: a single institution case review [J].
Niu, X. ;
Gilbert, L. .
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2011, 32 (04) :377-380
[23]   Role of Immunohistochemistry to Distinguish Grade 3 Endometrioid Carcinoma and Uterine Serous Carcinoma [J].
Zaidi, Ariba ;
Gupta, Parikshaa ;
Gupta, Nalini ;
Rajwanshi, Arvind ;
Rai, Bhavana ;
Gainder, Shalini .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) :42-48
[24]   Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma [J].
Chen, Xiaodan ;
Guo, Qingyong ;
Chen, Xiaorong ;
Zheng, Wanjing ;
Kang, Yaqing ;
Cao, Dairong .
BMC MEDICAL IMAGING, 2024, 24 (01)
[25]   Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma [J].
Mylonas, Ioannis ;
Schindlbeck, Christian .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (01) :207-214
[26]   PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus [J].
F. Kimura ;
J. Watanabe ;
H. Hata ;
T. Fujisawa ;
Y. Kamata ;
Y. Nishimura ;
T. Jobo ;
H. Kuramoto .
Journal of Cancer Research and Clinical Oncology, 2004, 130 :161-168
[27]   PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus [J].
Kimura, F ;
Watanabe, J ;
Hata, H ;
Fujisawa, T ;
Kamata, Y ;
Nishimura, Y ;
Jobo, T ;
Kuramoto, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (03) :161-168
[28]   Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix [J].
Hiroshi Kajiwara ;
Kenichi Hirabayashi ;
Masaki Miyazawa ;
Naoya Nakamura ;
Takeshi Hirasawa ;
Toshinari Muramatsu ;
Mikio Mikami ;
Masanori Yasuda ;
R. Y. Osamura .
Archives of Gynecology and Obstetrics, 2009, 279 :521-525
[29]   Neuroendocrine small cell carcinoma of the uterine cervix [J].
Reig Castillejo, Anna ;
Membrive Conejo, Ismael ;
Foro Arnalot, Palmira ;
Rodriguez de Dios, Nuria ;
Algara Lopez, Manuel .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (07) :512-513
[30]   Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix [J].
Kajiwara, Hiroshi ;
Hirabayashi, Kenichi ;
Miyazawa, Masaki ;
Nakamura, Naoya ;
Hirasawa, Takeshi ;
Muramatsu, Toshinari ;
Mikami, Mikio ;
Yasuda, Masanori ;
Osamura, R. Y. .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 279 (04) :521-525